| Literature DB >> 36114438 |
John Mills1, Cara Liebert2,3, Janey Pratt2,3, Michelle Earley3, Dan Eisenberg2,3.
Abstract
PURPOSE: The COVID-19 pandemic accelerated implementation of telehealth throughout the US healthcare system. At our institution, we converted a fully integrated multidisciplinary bariatric clinic from face-to-face visits to entirely telehealth video/telephone visits. We hypothesized telehealth would increase the number of provider/patient encounters and therefore delay time to surgery.Entities:
Keywords: Bariatric surgery; COVID-19; Telehealth; Veterans Health
Year: 2022 PMID: 36114438 PMCID: PMC9483527 DOI: 10.1007/s11695-022-06233-3
Source DB: PubMed Journal: Obes Surg ISSN: 0960-8923 Impact factor: 3.479
Demographics by treatment Group
| Treatment group | |||||
|---|---|---|---|---|---|
| Characteristic | Traditional ( | Telehealth ( | Total ( | p value | |
| Age | 0.752(a) | ||||
| Mean (s.d.) | 49.81 (12.28) | 48.53 (10.47) | 49.17 (11.35) | ||
| Min, Max | 27, 69 | 31, 71 | 27, 71 | ||
| Median (Q1, Q3) | 51.00 (39.50, 61.50) | 50.50 (37.50, 54.50) | 51.00 (39.00, 56.50) | ||
| Sex | Male | 26 (72%) | 21 (58%) | 47 (65%) | 0.216(b) |
| Female | 10 (28%) | 15 (42%) | 25 (35%) | ||
| Distance to hospital (miles) | 0.001(a) | ||||
| Mean (s.d.) | 593.17 (305.59) | 324.01 (287.02) | 458.59 (324.05) | ||
| Min, Max | 48, 1,243 | 10, 933 | 10, 1,243 | ||
| Median (Q1, Q3) | 672.50 (413.00, 763.50) | 170.00 (97.50, 595.50) | 535.00 (139.50, 679.00) | ||
| Distance to hospital (2 category) | Close (< = 200 miles) | 8 (22%) | 20 (56%) | 28 (39%) | 0.004(b) |
| Far (> 200 miles) | 28 (78%) | 16 (44%) | 44 (61%) | ||
| Distance to hospital (3 category) | Close (< = 200 miles) | 8 (22%) | 20 (56%) | 28 (39%) | 0.010(b) |
| Intermediate (> 200 miles—< = 700 miles | 17 (47%) | 12 (33%) | 29 (40%) | ||
| Far (> 700 miles) | 11 (31%) | 4 (11%) | 15 (21%) | ||
| BMI at intake | 0.068 (a) | ||||
| Mean (s.d.) | 47.99 (7.97) | 45.51 (7.59) | 46.75 (7.83) | ||
| Min, Max | 37.00, 69.60 | 36.20, 70.40 | 36.20, 70.40 | ||
| Median (Q1, Q3) | 45.00 (41.80, 53.40) | 42.30 (39.95, 48.25) | 45.00 (40.96, 51.85) | ||
| BMI pre-op | 0.468 (a) | ||||
| Mean (s.d.) | 47.00 (8.05) | 45.82 (8.00) | 46.41 (7.99) | ||
| Min, Max | 35.70, 70.00 | 35.90, 71.00 | 35.70, 71.00 | ||
| Median (Q1, Q3) | 46.25 (40.50, 51.70) | 44.25 (39.70, 49.25) | 45.00 (40.25, 49.70) | ||
| Comorbidities—behavioral health | No | 6 (17%) | 7 (19%) | 13 (18%) | 0.759 (b) |
| Yes | 30 (83%) | 29 (81%) | 59 (82%) | ||
| Comorbidities—CAD/CHF | No | 28 (78%) | 34 (94%) | 62 (86%) | 0.085 (c) |
| Yes | 8 (22%) | 2 (6%) | 10 (14%) | ||
| Comorbidities—DM | No | 18 (50%) | 26 (72%) | 44 (61%) | 0.053 (b) |
| Yes | 18 (50%) | 10 (28%) | 28 (39%) | ||
| Comorbidities—GERD | No | 16 (44%) | 17 (47%) | 33 (46%) | 0.813 (b) |
| Yes | 20 (56%) | 19 (53%) | 39 (54%) | ||
| Comorbidities—HLD | No | 17 (47%) | 18 (50%) | 35 (49%) | 0.814 (b) |
| Yes | 19 (53%) | 18 (50%) | 37 (51%) | ||
| Comorbidities—HTN | No | 15 (42%) | 21 (58%) | 36 (50%) | 0.157 (b) |
| Yes | 21 (58%) | 15 (42%) | 36 (50%) | ||
| Comorbidities—OSA | No | 9 (25%) | 11 (31%) | 20 (28%) | 0.599 (b) |
| Yes | 27 (75%) | 25 (69%) | 52 (72%) | ||
(a) Wilcoxon test—s.d., standard deviation; BMI, body mass index; DM, diabetes mellitus; HTN, hypertension
(b) Chi-square test—Min, minimum; CAD, coronary artery disease; GERD, gastro-esophageal reflux disease
(c) Fisher’s exact test—Max, maximum; CHF, congestive heart failure; HLD, hyperlipidemia; OSA, obstructive sleep apnea
(Unadjusted) Outcomes by treatment
| Treatment group | ||||
|---|---|---|---|---|
| Characteristic | Traditional ( | Telehealth ( | Total ( | |
| Time to Surgery (days) | ||||
| Mean (s.d.) | 307.92 (145.36) | 220.56 (103.39) | 264.24 (132.74) | |
| Min, Max | 105, 633 | 91, 525 | 91, 633 | |
| Median (Q1, Q3) | 295 (190, 418) | 192.00 (153.00, 250.50) | 233.50 (163.50, 341.00) | |
| Required additional preoperative testing? | No | 34 (94%) | 35 (97%) | 69 (96%) |
| Yes | 2 (6%) | 1 (3%) | 3 (4%) | |
| Number of actual pre-op visits total | ||||
| Mean (s.d.) | 6.03 (2.14) | 5.11 (1.37) | 5.57 (1.84) | |
| Min, Max | 3, 10 | 3, 9 | 3, 10 | |
| Median (Q1, Q3) | 5 (4, 8) | 5 (4, 6) | 5.00 (4.00, 6.50) | |
Fig. 1Time to surgery (days) by treatment group